MannKind | MNKD - Ordinary Share Capital

Stock Price
3.09
Daily Change
-0.13 -4.04%
Monthly
12.36%
Yearly
-29.29%
Q2 Forecast
3.03

MannKind reported $308.91M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Adma Biologics USD 237.88M 457K Dec/2025
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
Halozyme Therapeutics USD 118.52M 741K Mar/2026
Insmed USD 216.52M 2.27M Mar/2026
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
MannKind USD 308.91M 1.07M Mar/2026
Merck USD 2.47B 12.72M Dec/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Novavax USD 162.58M 106K Dec/2025
Novo Nordisk DKK 4.44B 3.99B Jun/2025
Pfizer USD 5.7B 13M Mar/2026
Sanofi EUR 1.21B 8.25M Mar/2026
Xencor USD 74.06M 2.19M Mar/2026